Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BBNX

Beta Bionics Inc

Sep 15 • 03:56PM ET

25.45

-0.96 -3.63 %

Healthcare • Medical Devices • USA • NASD

Held by: IWM VTI IWO VXF SCHA VTWO SNSR ITOT IWN SCHB

Index	RUT	P/E	-	EPS (ttm)	-1.69	Insider Own	24.66%	Shs Outstand	43.47M	Perf Week	10.04%
Market Cap	1.11B	Forward P/E	-	EPS next Y	-1.84	Insider Trans	-0.65%	Shs Float	32.75M	Perf Month	52.31%
Enterprise Value	863.34M	PEG	-	EPS next Q	-0.42	Inst Own	87.75%	Short Float	9.50%	Perf Quarter	33.32%
Income	-73.37M	P/S	14.18	EPS this Y	75.78%	Inst Trans	16.35%	Short Ratio	5.13	Perf Half Y	73.49%
Sales	78.02M	P/B	3.67	EPS next Y	11.89%	ROA	-42.17%	Short Interest	3.11M	Perf YTD	7.71%
Book/sh	6.94	P/C	4.43	EPS next 5Y	40.20%	ROE	-81.35%	52W High	26.66 -4.53%	Perf Year	-
Cash/sh	5.74	P/FCF	-	EPS past 3/5Y	8.56% -	ROIC	-23.91%	52W Low	8.89 186.29%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	1807.41% -	Gross Margin	56.22%	Volatility	9.49% 7.54%	Perf 5Y	-
Dividend TTM	-	EV/Sales	11.07	EPS Y/Y TTM	-34.11%	Oper. Margin	-80.14%	ATR (14)	1.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	13.79	Sales Y/Y TTM	97.91%	Profit Margin	-94.04%	RSI (14)	77.43	Recom	1.44
Dividend Gr. 3/5Y	- -	Current Ratio	14.68	EPS Q/Q	-16.34%	SMA20	26.03%	Beta	-	Target Price	23.67
Payout	-	Debt/Eq	0.02	Sales Q/Q	54.45%	SMA50	51.24%	Rel Volume	1.31	Prev Close	26.41
Employees	291	LT Debt/Eq	0.02	Earnings	Jul 29 AMC	SMA200	57.09%	Avg Volume	606.57K	Price	25.45
IPO	Jan 30, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	15.01% 18.04%	Trades		Volume	787,119	Change	-3.63%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Truist	Buy	$26
Jun-12-25	Initiated	Lake Street	Buy	$30
May-30-25	Initiated	Wolfe Research	Outperform	$20
May-30-25	Initiated	Goldman	Neutral	$16
Feb-24-25	Initiated	Stifel	Buy	$25
Feb-24-25	Initiated	Piper Sandler	Overweight	$26
Feb-24-25	Initiated	Leerink Partners	Outperform	$28
Feb-24-25	Initiated	Lake Street	Buy	$30
Feb-24-25	Initiated	BofA Securities	Buy
Feb-20-25	Initiated	Robert W. Baird	Neutral	$20
Feb-20-25	Initiated	Ladenburg Thalmann	Neutral	$20

Show Previous Ratings

Aug-21-25 08:00AM	Beta Bionics Announces Participation at Upcoming Investor Conferences (GlobeNewswire) +10.39%
Jul-30-25 03:17AM	Beta Bionics Inc (BBNX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +14.32%
Jul-29-25 04:02PM	Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance (GlobeNewswire)
03:20PM	Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival (Bloomberg)
Jul-04-25 02:43AM	Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas (Insider Monkey)
07:30AM	Loading…
Jul-02-25 07:30AM	Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 (GlobeNewswire)
Jun-24-25 03:59PM	Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions (GlobeNewswire)
06:56AM	ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors (MedTech Dive)
Jun-23-25 11:20AM	BBNX Stock May Gain From Abbott Deal to Advance iLet Integration (Zacks) -11.68%
Jun-20-25 07:06AM	5 things to watch at the ADAs Scientific Sessions (MedTech Dive)
Jun-19-25 07:00AM	Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor (GlobeNewswire)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-02-25 05:01AM	Beta Bionics CEO, CFO on how to take a company public (MedTech Dive) +8.41%
May-29-25 05:44AM	The medtech IPO window is finally open. Or is it? (MedTech Dive) +6.44%
May-07-25 03:22AM	Beta Bionics Inc (BBNX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com) +26.61%
04:02PM	Loading…
May-06-25 04:02PM	Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 (GlobeNewswire)
May-01-25 08:00AM	Beta Bionics to Present at the Bank of America Securities Health Care Conference (GlobeNewswire)
Apr-24-25 11:44AM	Beta Bionics: Slowing Down Or Being Conservative? (Seeking Alpha) +5.74%
Apr-19-25 05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-16-25 04:05PM	Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-09-25 07:30AM	Beta Bionics to Host Investor Event on June 22, 2025 (GlobeNewswire) +21.63%
Mar-28-25 06:00AM	Newly public Beta Bionics reports sales surge; Dexcom hires CCO (MedTech Dive) -7.58%
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
Mar-25-25 04:02PM	Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 (GlobeNewswire) -13.60%
Mar-03-25 12:59PM	Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently (Insider Monkey)
Feb-27-25 07:00AM	Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 (GlobeNewswire)
Feb-21-25 09:35AM	Palantir initiated, Roku upgraded: Wall Streets top analyst calls (TipRanks)
Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
10:34PM	Loading…
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Feider Stephen	Chief Financial Officer	Sep 08 '25	Option Exercise	5.10	9,900	50,490	53,941	Sep 09 04:12 PM
Feider Stephen	Chief Financial Officer	Sep 08 '25	Sale	21.13	9,900	209,151	44,041	Sep 09 04:12 PM
Hopman Mark	Chief Commercial Officer	Sep 05 '25	Option Exercise	5.10	11,411	58,196	42,626	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 04 '25	Option Exercise	5.10	4,749	24,220	38,033	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 05 '25	Sale	20.56	11,411	234,657	31,215	Sep 08 06:15 PM
Hopman Mark	Chief Commercial Officer	Sep 04 '25	Sale	19.97	6,818	136,180	31,215	Sep 08 06:15 PM
Feider Stephen	Chief Financial Officer	Sep 05 '25	Option Exercise	5.10	100	510	44,141	Sep 08 06:15 PM
Feider Stephen	Chief Financial Officer	Sep 05 '25	Sale	21.00	100	2,100	44,041	Sep 08 06:15 PM
Feider Stephen	Officer	Sep 08 '25	Proposed Sale	21.13	9,900	209,152		Sep 08 02:23 PM
Hopman Mark	Officer	Sep 05 '25	Proposed Sale	20.56	11,411	234,657		Sep 05 05:24 PM
Feider Stephen	Officer	Sep 05 '25	Proposed Sale	21.00	100	2,100		Sep 05 05:12 PM
Saint Sean	President & CEO	Sep 02 '25	Sale	18.86	3,359	63,361	101,202	Sep 04 06:45 PM
Russell Steven Jon	Chief Medical Officer	Sep 02 '25	Sale	18.86	1,015	19,146	71,017	Sep 04 06:45 PM
Mensinger Mike	Chief Product Officer	Sep 02 '25	Sale	18.86	1,089	20,542	91,815	Sep 04 06:45 PM
Hopman Mark	Chief Commercial Officer	Sep 02 '25	Sale	18.86	848	15,996	33,284	Sep 04 06:45 PM
Feider Stephen	Chief Financial Officer	Sep 02 '25	Sale	18.86	1,462	27,578	44,041	Sep 04 06:45 PM
Hopman Mark	Officer	Sep 04 '25	Proposed Sale	19.97	6,818	136,180		Sep 04 04:33 PM
Feider Stephen	Chief Financial Officer	Aug 22 '25	Option Exercise	5.10	4,413	22,506	49,916	Aug 26 04:29 PM
Feider Stephen	Chief Financial Officer	Aug 22 '25	Sale	17.01	4,413	75,083	45,503	Aug 26 04:29 PM
Feider Stephen	Officer	Aug 22 '25	Proposed Sale	17.01	4,413	75,083		Aug 22 11:10 AM
Hopman Mark	Chief Commercial Officer	Aug 19 '25	Option Exercise	5.10	16,158	82,406	50,290	Aug 20 09:30 PM
Hopman Mark	Chief Commercial Officer	Aug 19 '25	Sale	16.61	16,158	268,376	34,132	Aug 20 09:30 PM
Feider Stephen	Chief Financial Officer	Aug 19 '25	Option Exercise	5.10	5,587	28,494	51,090	Aug 20 09:30 PM
Feider Stephen	Chief Financial Officer	Aug 19 '25	Sale	17.03	5,587	95,172	45,503	Aug 20 09:30 PM
Feider Stephen	Officer	Aug 19 '25	Proposed Sale	17.03	5,587	95,172		Aug 19 05:41 PM
Hopman Mark	Officer	Aug 19 '25	Proposed Sale	16.61	16,158	268,376		Aug 19 05:30 PM
Sean Saint	Officer	Jun 02 '25	Proposed Sale	17.89	3,439	61,524		Jun 09 08:30 PM
Hopman Mark	Chief Commercial Officer	Jun 02 '25	Sale	17.89	868	15,529	34,132	Jun 04 07:30 PM
Russell Steven Jon	Chief Medical Officer	Jun 02 '25	Sale	17.89	1,039	18,588	72,032	Jun 04 07:30 PM
Mensinger Mike	Chief Product Officer	Jun 02 '25	Sale	17.89	1,115	19,948	92,904	Jun 04 07:30 PM
Feider Stephen	Chief Financial Officer	Jun 02 '25	Sale	17.89	1,497	26,783	45,503	Jun 04 07:30 PM
Saint Sean	President & CEO	Jun 02 '25	Sale	17.89	3,439	61,526	104,561	Jun 04 07:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Buy	17.00	33,350	566,950	59,019	Feb 03 08:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Sale	17.00	13	221	25,669	Feb 03 08:30 PM
Wellington Hadley Harbor Aggre	10% Owner	Jan 31 '25	Buy	17.00	1,000,000	17,000,000	3,901,599	Feb 03 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your FINVIZ experience